🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ultra-rapid Blastocyst Vitrification: Pilot Randomized Study

RecruitingNAAges 18 Years - 50 YearsFemaleFundacion Dexeus
NCT07556601 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Blastocyst vitrification is standard in assisted reproduction, but clinical data on ultra-rapid vitrification are limited. This pilot study evaluates the safety, feasibility, and preliminary clinical performance of an ultra-rapid blastocyst vitrification protocol compared with the standard approach.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Recipients of donor oocytes * Blastocysts suitable for cryopreservation Exclusion Criteria: * Cycles involving PGT * Cycles not reaching blastocyst stage.
💊

What it tests

  • Standard Vitrification
  • Ultra-Rapid Vitrification
📍

Where

2 sites
Hospital Universitario Quiron Dexeus
Barcelona, Spain
Hospital Universitario Quiron Dexeus
Barcelona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy